
### [NCIT:C8842](http://purl.obolibrary.org/obo/NCIT_C8842)
**Label:** Refractory B-Cell Non-Hodgkin Lymphoma

**Subclasses:** [NCIT:C4997](http://purl.obolibrary.org/obo/NCIT_C4997) (Refractory Nodal Marginal Zone Lymphoma), [NCIT:C8927](http://purl.obolibrary.org/obo/NCIT_C8927) (Refractory Centroblastic Lymphoma), [NCIT:C8847](http://purl.obolibrary.org/obo/NCIT_C8847) (Refractory Burkitt Lymphoma), [NCIT:C8858](http://purl.obolibrary.org/obo/NCIT_C8858) (Refractory Follicular Lymphoma), [NCIT:C8846](http://purl.obolibrary.org/obo/NCIT_C8846) (Refractory Small Lymphocytic Lymphoma), [NCIT:C138028](http://purl.obolibrary.org/obo/NCIT_C138028) (Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), [NCIT:C7228](http://purl.obolibrary.org/obo/NCIT_C7228) (Refractory Mature B-Cell Non-Hodgkin Lymphoma), [NCIT:C8853](http://purl.obolibrary.org/obo/NCIT_C8853) (Refractory Diffuse Large B-Cell Lymphoma), [NCIT:C8875](http://purl.obolibrary.org/obo/NCIT_C8875) (Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8652](http://purl.obolibrary.org/obo/NCIT_C8652) (Refractory Lymphoplasmacytic Lymphoma), [NCIT:C8862](http://purl.obolibrary.org/obo/NCIT_C8862) (Refractory Mantle Cell Lymphoma), [NCIT:C138026](http://purl.obolibrary.org/obo/NCIT_C138026) (Refractory Intravascular Large B-Cell Lymphoma), [NCIT:C8870](http://purl.obolibrary.org/obo/NCIT_C8870) (Refractory B Lymphoblastic Lymphoma), [NCIT:C5096](http://purl.obolibrary.org/obo/NCIT_C5096) (Refractory Splenic Marginal Zone Lymphoma), [NCIT:C5090](http://purl.obolibrary.org/obo/NCIT_C5090) (Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), 

**Class expressions from DL-Learner:**

- Thing 53.00%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40066](http://purl.obolibrary.org/obo/NCIT_C40066) (Undifferentiated Ovarian Sarcoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40063](http://purl.obolibrary.org/obo/NCIT_C40063) (Ovarian Low Grade Endometrioid Stromal Sarcoma))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40061](http://purl.obolibrary.org/obo/NCIT_C40061) (Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation))) 38.93%


